Drug resistance (DR) in is the main problem in fighting tuberculosis (TB). This pathogenic bacterium has several types of DR implementation: acquired and intrinsic DR. Recent studies have shown that exposure to various antibiotics activates multiple genes, including genes responsible for intrinsic DR. To date, there is evidence of the acquisition of resistance at concentrations well below the standard MICs. In this study, we aimed to investigate the mechanism of intrinsic drug cross-resistance induction by subinhibitory concentrations of antibiotics. We showed that pretreatment of with low doses of antibiotics (kanamycin and ofloxacin) induced drug resistance. This effect may be caused by a change in the expression of transcriptional regulators of the mycobacterial resistome, in particular the main transcriptional regulator .
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135989 | PMC |
| http://dx.doi.org/10.3390/biology12040506 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Analysis of the Results of Tuberculosis Drug Resistance Surveillance in Yuexiu District, Guangzhou City, 2013-2022.
Immun Inflamm Dis
November 2024
State Key Laboratory of Respiratory Disease, Guangzhou Key Laboratory of Tuberculosis, Guangzhou Chest Hospital, Institute of Tuberculosis, Guangzhou Medical University, Guangzhou, China.
Article Synopsis
- The study investigates drug resistance trends in tuberculosis patients in Yuexiu District, Guangzhou City, over a nine-year period from 2013 to 2022 to inform better prevention and control strategies.
- Out of 5,191 active tuberculosis patients analyzed, 1,659 Mycobacterium tuberculosis strains were cultured, resulting in 438 cases of drug resistance.
- The overall drug resistance rate was 26.40%, with significant findings including 15.37% monoresistance, 7.29% polyresistance, and 3.74% multidrug resistance, with the highest resistance observed to streptomycin and isoniazid.
Evaluating culture-free targeted next-generation sequencing for diagnosing drug-resistant tuberculosis: a multicentre clinical study of two end-to-end commercial workflows.
Lancet Infect Dis
October 2024
FIND, Geneva, Switzerland; Division of Pulmonary, Critical Care, Sleep Medicine, and Physiology, University of San Diego, San Diego, CA, USA.
Background: Drug-resistant tuberculosis remains a major obstacle in ending the global tuberculosis epidemic. Deployment of molecular tools for comprehensive drug resistance profiling is imperative for successful detection and characterisation of tuberculosis drug resistance. We aimed to assess the diagnostic accuracy of a new class of molecular diagnostics for drug-resistant tuberculosis.
View Article and Find Full Text PDFA rapid and simple modified nitrate reductase assay for testing first and second-line antituberculosis drug susceptibilities in Mycobacterium tuberculosis isolates.
Diagn Microbiol Infect Dis
December 2024
Faculty of Health Sciences Research Laboratory, Tuberculosis Research Unit, Akdeniz University, Antalya, Türkiye; Faculty of Health Sciences, Department of Nutrition and Dietetics, Antalya, Türkiye; Department of Medical, Biotechnology, Institute of Health Sciences, Akdeniz University, Antalya, Türkiye. Electronic address:
In this study, we developed a modified NRA (MONRA) to determine the first and second-line drug susceptibilities of 5 reference ATCC strains and 42 clinical M. tuberculosis isolates. Unlike conventional NRA, which is often performed in solid media or 7H9 broth, the MONRA is performed in a different medium, AYC.
View Article and Find Full Text PDFThe catalogue of Mycobacterium tuberculosis mutations associated with drug resistance to 12 drugs in China from a nationwide survey: a genomic analysis.
Lancet Microbe
November 2024
National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China; National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, China. Electronic address:
Background: WHO issued the first edition catalogue of Mycobacterium tuberculosis complex (MTBC) mutations associated with drug resistance in 2021. However, country-specific issues might lead to arising complex and additional drug-resistant mutations. We aimed to fully reflect the characteristics of drug resistance mutations in China.
View Article and Find Full Text PDFA biomimetic human disease model of bacterial keratitis using a cornea-on-a-chip system.
Biomater Sci
October 2024
School of Ophthalmology & Optometry, Eye Hospital, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Bacterial keratitis is a common form of inflammation caused by the bacterial invasion of the corneal stroma after trauma. In extreme cases, it can lead to severe visual impairment or even blindness; therefore, timely medical intervention is imperative. Unfortunately, widespread misuse of antibiotics has led to the development of drug resistance.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!